LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
44.33
-2.34 (-5.01%)
At close: Jul 11, 2025, 4:00 PM
45.13
+0.80 (1.80%)
After-hours: Jul 11, 2025, 5:02 PM EDT
LivaNova Employees
LivaNova had 2,900 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,900
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$439,786
Profits / Employee
-$76,602
Market Cap
2.42B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LIVN News
- 3 days ago - LivaNova to Announce Second-Quarter 2025 Results - Business Wire
- 4 days ago - LivaNova: The Sell-Off Is Excessive Here - Seeking Alpha
- 5 weeks ago - CORE-VNS Study Further Validates Effectiveness of LivaNova's VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy - Business Wire
- 5 weeks ago - LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy - Business Wire
- 5 weeks ago - LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression - Business Wire
- 2 months ago - LivaNova to Present at the Jefferies Global Healthcare Conference - Business Wire
- 2 months ago - LivaNova PLC (LIVN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance - Business Wire